Recent research from Stanford Medicine challenges the prevailing approach of studying brain function by relying on averaged data from multiple…

In a groundbreaking leap for optical physics and bioimaging technology, researchers at the Massachusetts Institute of Technology (MIT) have unveiled…

In the ever-evolving landscape of pediatric medicine, one of the most pressing challenges remains the early identification of neurodevelopmental disorders…

Emerging research reveals a compelling connection between cardiovascular-kidney-metabolic (CKM) syndrome and an elevated risk of cancer development, shedding new light…

Oruka Therapeutics’ long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a trial, leading Jefferies analysts…

In the ever-evolving field of geriatric medicine, the ability to accurately predict hospital outcomes in older adults remains a critical…

A phase 3 trial of Intellia Therapeutics’ in vivo gene editing therapy lonvoguran ziclumeran (lonvo-z) has hit its primary endpoint, leading…